[NLS-RARα transports into the nucleus by binding to importin α1/β2(KPNA2/KPNB1) and inhibits the differentiation of U937 cells].


Journal

Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
ISSN: 1007-8738
Titre abrégé: Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
Pays: China
ID NLM: 101139110

Informations de publication

Date de publication:
Jun 2020
Historique:
entrez: 23 7 2020
pubmed: 23 7 2020
medline: 31 10 2020
Statut: ppublish

Résumé

Objective To investigate the inhibitory effect of abnormal nuclear localization of the nuclear localization signal-retinoic acid receptor α (NLS-RARα) on cell differentiation and its mechanism of nuclear transport. Methods Over-expression of HA-NLS-RARα and empty vector in HEK293T cells and U937 cells were achieved through a lentivirus vector and were assigned as NLS-RARα over-expression (NR) group and negative control (NC) group. Extracted nucleoproteins and cytosolic proteins of NC and NR groups of HEK293T cells and U937 cells were detected by Western blot analysis in order to demonstrate the localization of NLS-RARα. Meanwhile, immunofluorescence assay was performed to explore the localization of NLS-RARα. The real-time quantitative PCR and Western blot analysis were used to detect difference in the mRNA and protein expression of CD11b and CEBPβ in the NR cells treated with 1, 25-dihydroxyvitamin D3 (1, 25D3) compared with NC cells treated with 1, 25D3. Mass spectrometric analysis and co-immunoprecipitation were conducted to screen the transport proteins which were associated with NLS-RARα, which was followed by the verification of nuclear accumulation of NLS-RARα by the transfection of transport protein small interfering RNA. Results Western blot assay and immunofluorescence showed that NLS-RARα was mainly located in the nucleus. And the qRT-PCR analysis and western blot assay showed a significant decrease in the mRNA and protein expression of CD11b and CEBPβ in the NR group compared with the NC group. It demonstrated that NLS-RARα inhibited cell differentiation. Mass spectrometric analysis and COIP demonstrated that KPNA2 (importin α1) and KPNB1 (importin β1) interacted with NLS-RARα, and the knockdown of KPNA2/KPNB1 inhibited the nuclear accumulation of NLS-RARα. Conclusion Abnormal localization of NLS-RARα inhibits cell differentiation via binding to KPNA2 and KPNB1 into the nucleus.

Identifiants

pubmed: 32696739

Substances chimiques

KPNA2 protein, human 0
KPNB1 protein, human 0
Nuclear Localization Signals 0
Retinoic Acid Receptor alpha 0
alpha Karyopherins 0
beta Karyopherins 0

Types de publication

Journal Article

Langues

chi

Sous-ensembles de citation

IM

Pagination

499-506

Auteurs

Jiao Ye (J)

Ministry-of-Education Key laboratory of Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016; Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Beizhong Liu (B)

Ministry-of-Education Key laboratory of Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016; Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Jian Li (J)

Ministry-of-Education Key laboratory of Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.

Ling Xiong (L)

Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Lihua Yu (L)

Department of Laboratory Medicine, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Wenran Dan (W)

Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Dongdong Liu (D)

Ministry-of-Education Key laboratory of Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.

Juanjuan Yao (J)

Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Zhen Yuan (Z)

Ministry-of-Education Key laboratory of Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China.

Pengqiang Zhong (P)

Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Junmei Liu (J)

Central Laboratory, Yongchuan Hospital, Chongqing Medical University, Chongqing 402160, China.

Liang Zhong (L)

Ministry-of-Education Key laboratory of Clinical Laboratory Diagnostics, Department of Laboratory Medicine, Chongqing Medical University, Chongqing 400016, China. *Corresponding author, E-mail: zhongliang@cmqu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH